ArticleEuropean journal of cancer (Oxford, England : 1990)2022

Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma.

Matt Lechner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.